Afya Limited (NASDAQ:AFYA – Get Free Report) VP Lelio De Souza Junior sold 36,204 shares of the firm’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $15.00, for a total value of $543,060.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Lelio De Souza Junior also recently made the following trade(s):
- On Friday, June 26th, Lelio De Souza Junior sold 41,541 shares of Afya stock. The stock was sold at an average price of $15.00, for a total value of $623,115.00.
- On Thursday, April 9th, Lelio De Souza Junior sold 16,279 shares of Afya stock. The shares were sold at an average price of $14.53, for a total value of $236,533.87.
- On Tuesday, April 7th, Lelio De Souza Junior sold 26,753 shares of Afya stock. The shares were sold at an average price of $14.95, for a total transaction of $399,957.35.
Afya Trading Down 0.7%
Shares of AFYA opened at $14.77 on Wednesday. The stock has a market capitalization of $1.38 billion, a PE ratio of 9.65, a P/E/G ratio of 1.48 and a beta of 0.32. The company’s fifty day moving average is $14.30 and its 200 day moving average is $14.54. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.78 and a current ratio of 1.78. Afya Limited has a fifty-two week low of $13.00 and a fifty-two week high of $17.30.
Hedge Funds Weigh In On Afya
Analyst Upgrades and Downgrades
A number of brokerages recently commented on AFYA. Zacks Research downgraded shares of Afya from a “strong-buy” rating to a “hold” rating in a report on Wednesday, May 6th. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research note on Monday, April 20th. Wall Street Zen downgraded Afya from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 2nd. Bank of America reaffirmed a “neutral” rating on shares of Afya in a research note on Thursday, June 11th. Finally, JPMorgan Chase & Co. cut their target price on Afya from $21.50 to $21.00 and set a “neutral” rating on the stock in a research report on Monday, June 22nd. One research analyst has rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, Afya has an average rating of “Hold” and an average target price of $17.10.
Check Out Our Latest Analysis on AFYA
Afya Company Profile
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Recommended Stories
- Five stocks we like better than Afya
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
